UK'S MHRA:
UK'S MHRA: APPROVES RETIFANLIMAB (ZYNYZ) FOR THE TREATMENT OF ADVANCED MERKEL CELL SKIN CANCER
Reuters
UK's MHRA Approves Retifanlimab For Treatment Of Advanced Merkel Cell Skin Cancer
- Sources
- Reuters
- Markets
- Economy, Stocks
- Active symbols
- NASDAQ:INCY
- Language
- English
UK'S MHRA: